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The human body is a beautiful specialized engine and there is not any 
other machine like it. Your body will always do everything 
possible to stay healthy; in its interior it will sacrifice some things 
for others in order to conserve the equilibrium. 
1. Introduction 
Obesity is an alteration of body composition characterized by excess adipose tissue, that 
involves an imbalance between energy intake and output, which can be produced by a 
series of genetic, biochemical, dietary and behavioral alterations; therefore, it could be 
viewed as a multifactorial disease, in which inside the body it can find various regulatory 
elements of the system of feeling hunger-satiety signals commanded by chemicals that 
regulate food intake. The environment plays an important role in the development of 
cultural elements of each individual, determining the amount, type, and frequency of 
consumption of foods; this also determines their nutritional status. Eastern societies have 
based their feeding in legumes such as soybeans. These groups have low rates of obesity, 
which has drawn wide attention towards these foods and especially soybeans. Soy is a 
valuable food from a nutritional standpoint, because its protein is among the highest 
biological value, its lipids are mostly polyunsaturated, contains fiber and carbohydrates, is 
rich in vitamins and minerals; additionally containing various phytochemicals with 
antioxidant and anti-obesity activity. Several studies in experimental animals and humans 
have shown that a diet whose protein content is based on soy protein, have a beneficial 
effect in obese individuals as measured by the decrease in body weight associated with the 
body calorie intake, liver triglycerides, cholesterol, hepatic synthesis of fatty acids, enzymes 
responsible for mRNA synthesis of fatty acids and hyperinsulinemia. Moreover, the soy 
protein has been shown to contribute to the increase in LDL receptors, the increase in insulin 
sensitivity, and also in the activity of enzymes responsible for fatty acid metabolism, 
especially those involved in the β-oxidation. Considering the above, in this chapter shall be 
reviewed how the consumption of soybean and soybean sprouts may reduce the incidence 
of obesity and diseases closely related to it as the Diabetes Mellitus and Cardiovascular 
Disease.  
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2. Obesity 
Through the years, the world has lived terrible wars, in which many people survived in 
extreme conditions. Under these circumstances, the body created defense mechanisms that 
would allow it survives on similar conditions relying on fat. This is particularly important in 
any energy deprivation state such as prolonged fasting, skipping meals, performing to much 
exercise and not feeding correctly. However, nowadays there is a general tendency to 
cumulate fat; the excess of this component is associated with obesity. 
When a disease is produced by multiple factors, a lot of different definitions and etiological 
explanations arise, such is the case of obesity, in which the conceptual analysis can be as 
diverse depending on the focus from which it is signaled. The definition varies from the 
clearest and simplest concept: “the alteration of the body composition characterized for an 
excess of adipose tissue”, through the most complex concept: “Unbalance between food intake 
and energy expenditure produced by series of genetic, biochemical, dietary and behavior 
alterations.” Besides, the problem gets worse when it involves different population factors as 
ethnicity, dietary habits and the decrease of the vulnerability to diseases that previously 
limited life expectancy and conferred the opportunity to gain weight. 
In many affected subjects it is clear that overfeeding and low physical activity causes an 
accumulation of excessive body fat.  Currently there are many individual differences in the 
energy processing and tendency to calorie storing. Below we will provide a brief description 
of the great complex interrelated factors. Exposing different causes, we can constitute a 
group of syndromes based on diverse origins. Unfortunately it is a combination of these 
factors the ones that affect the majority of the population (Figure 1). 
 
Genetic 
Factors
Environmental 
Factors
OBESITY
Physiological 
Factors
Psychological 
Factors
 
Fig. 1. Obesity Etiology. The obesity has origin in four main factors: genetic, physiological, 
environmental and psychosocial. 
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Genetic Factors 
Genetics seems to establish the obesity scenario; nevertheless, diet, exercise and life style 
will be the ones determining the magnitude of the problem, for that reason it is convenient 
to analyze the physiological pathology of obesity from a wider focus. 
Some studies based on comparing the behavior of identical twins exposed to different 
environmental conditions established that the impact of genetics, as an obesity causal factor, 
was approximately 30-40%, while environment was ascribed 60-70% (Bouchard, et al. 1993). 
Although other researches report an interval between 20 to 80%, depending on some 
particular characteristics of obesity or age of appearance (Groop & Orho-Melander, 2001). 
In the research of the genetic factors that modulate satiety and body mass, several studies have 
been realized in animal models. In transgenic animal models has been studied the role of 
genes involved in the body fat increase as the effect related to the suppression of melanocortin-
4 receptor, the reduction of glucocorticoid receptor in brain, the over expression of the 
corticotrophin releasing hormone, suppression of uncoupling protein in brown adipose tissue, 
the over expression of agouti protein, the suppression of ǃ-3 adrenergic receptor and 
dysfunction of GLUT-4 in fat and intracellular adhesion molecule-1. 
In humans, there are clearly identified genetic syndromes in which obesity is a 
characteristic, such as Prader-Willi and Bardet-Biedl syndrome. However, obesity-related 
genetic alterations have been identified only in very few individuals. These alterations may 
be mutations in leptin and its receptor, melanocortin-4 receptor, propiomelanocortin, 
endopeptidase, prohormone convertase-1, in ǃ-3 adrenergic receptor, peroxisome 
proliferator-activated receptor-Ǆ2, among others (Figure 2). Despite the discovery of these 
single-gene disorders, the genetic model in the most cases of obesity in humans is non-
Mendelian polygenic. In the genomics of obesity in humans, it has been determined that 
there are at least 15 genes that were significantly associated with body fat or the percentage 
of body fat, and 5 genes are associated with abdominal visceral fat (Sims, 2001), although 
surveys of large populations have identified over 250 genes, markers and chromosomal  
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Fig. 2. Genetic factors of obesity. Two hundred and fifty genes have been related with 
obesity. Melanocortin and glucocorticoid receptors, corticotrophin-releasing hormone, 
uncoupling proteins, Agouti protein and transcription factors 
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regions associated with obesity (Perusse et al., 2000). Therefore, in humans, the potential 
interactions among multiple genes and their interaction with the environment, lead to the 
phenotypic expression of obesity. 
Physiological factors 
The accumulation of body fat requires an increment on the relation between intake and 
energy expenditure during a long period. However the simplicity of this premise vanishes 
when the modulator effect of other physiological variables as intrauterine development 
influences, hormonal functions (growth hormone and reproductive hormone) and the fine 
regulation of the feedback systems that try to keep a constant energy balance are included. 
In a study of obese and non-obese subjects with periods of caloric restriction and excess of 
calorie consumption, it was observed a decrease in the total and resting energy expenditure 
when they lost 10-20% body weight, possibly due to the adaptation of caloric deprivation. 
With the increase of weight it was observed increment on the energy expenditure, which 
delayed weight gain. These findings suggest the existence of a compensator mechanism that 
tends to maintain body weight (Leibel et al., 1995). 
Physiologically, there are many hormones and peptides that act in a feedback system 
composed of gastrointestinal system, adipocytes, hypothalamus and the hypothalamic-
pituitary-adrenal axis. The main appetite suppressants, at gastrointestinal level, are the 
glucagon-like peptide-1, the 6-29 amino acid segment of glucagon, cholecystokinin, 
enterostatin, the peptide YY 3-36 and the ghrelin. In addition, gastric distension and 
contractions produce signals of satiety and decreased appetite. This highly accurate system 
is also influenced by the serum glucose concentrations.  When glycemia is reduced about 
10% it causes an increase of appetite (Campfield et al., 1985).  
The discovering of leptin and its receptor interactions has established new paths for 
investigation on obesity physiopathology. Although it have been established that leptin is a 
fundamental protein in the energy equilibrium in rodents, the physiological role and the 
regulatory mechanisms of its secretions in humans have been object of great interest. 
This protein hormone is secreted by adipocytes in response to activation of insulin 
receptors, adipogenic hormones, adrenergic receptor, and also when detecting fat repletion. 
That secretion has a periodicity of 7 min and diurnal variation. When the hormone is 
liberated, it stimulates to its receptor located in the paraventricular nucleus of the 
hypothalamus which induces the release of the neurpeptide, whose main functions are 
appetite suppression and the stimulation of the thyroid function, the sympathetic nervous 
system and, of the thermogenesis. All these effects tend to limit weight gain. Therefore, the 
adipocyte and the hypothalamus form a classic feedback mechanism in which the 
adipogenesis and lypolisis are revealed as highly regulated processes (Figure 3). 
Aside of this path there are many afferent signals that affects the intake and energy 
expenditure. The adipocyte also receives signals from the gastrointestinal tract, the 
peripheral nervous system and the endocrine system. The integration of these systems 
involves the adequate adaptation to food deprivation periods, but it also leads to a poor 
adaptation to overfeeding. 
Several studies have confirmed direct interaction between hyperleptinemia and the 
percentage of body fat that suggests a leptin resistance (Rosenbaum et al., 1997). This 
resistance can occur at different levels: in the transport across the hematoencephalic barrier, 
in its hypothalamic receptor and/or other neural circuits in which this hormone influences. 
Recent studies have shown hypertrigliceridemia-mediated alterations in the transport of 
leptin through the hematoencephalic barrier (Banks et al., 2004).  
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Fig. 3. Role of leptin on energy intake. Leptin is a 16 kDa protein hormone that plays a key 
role in regulating energy intake and energy expenditure, including appetite and 
metabolism. 
Besides the role of leptin in the origin of obesity, have emerged reports about the deleterious 
effect of hyperleptinemia on the complications of obesity. It has been reported that leptin 
causes insulin resistance in hepatocytes (effect mediated by the dephosphorylation of 
insulin receptor substrate-1) and has fibrosis-inducing effects in various chronic liver 
diseases of metabolic or toxic etiology (Cohen et al., 1996; Crespo et al., 2002; Leclercq et al, 
2002).   
The hypothalamus exerts control over appetite, satiety and thermogenesis. To carry out this 
function, the hypothalamus requires mediators such as afferent hormonal signals (leptin, 
glucose), and regulation by the autonomic nervous system, through vagal afferents from 
gastrointestinal system and even from oropharyngeal stimulus. The main sites involved in 
this regulation are the nucleus of the solitary tract, the arcuate and paraventricular nucleus, 
as well as the ventromedial and lateral regions of the hypothalamus and amigdala. Leptin 
acts on the control of satiety in the arcuate and ventromedial nucleus. When there is 
destruction of the ventromedial hypothalamus, leptin is unable to suppress food intake at 
this level. In this process is also involved a large number of monoamines (such as 
norepinephrine and serotonin) and other neurotransmitters or neuromodulaters (Campfield, 
2000) (Figure 4). 
Other metabolic abnormalities related to obesity pathogeny are the defects on the lypolisis 
regulation (Sheehan & Jensen, 2000), actions in adipose tissue of rennin-angiotensin system 
(Goossen et al., 2003), tumor necrosis factor (TNF) (Bulló et al., 1999), and several 
neuropeptide systems (Cummin & Schwartz, 2003; PI-Sunyer, 2002). In this final sections, it  
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Fig. 4. Appetite control. The fluctuation of some molecules and hormone levels results in the 
motivation of an organism to consume food. 
has been implicated the autonomic nervous system imbalance with obesity and metabolic 
syndrome. In animal models with beta-adrenergic receptors suppressed, there is a severe 
obesity due to failure in diet-induced thermogenesis (Bachman et al., 2002). Pima population 
studies have linked the low adrenal sympathetic activity to weight gain (Tatarann, 1997). 
Another etiological factor of supreme importance is the aging process, in which, there are 
various elements that determine the weight gain and the changes in body fat distribution, 
such as the decreased physical activity and metabolic responses to dietary or environmental 
modifications; hormonal changes, for example, the decline in estrogens and progesterone 
that alters the adipocyte biology; the emergence of comorbidities, as well as behavioral 
disturbances and depression among others. 
As we move on obesity knowledge, new routes and pathophysiological interactions are 
discovered and it will be increasingly difficult to attribute them a greater pathogenic impact.  
Environmental factors 
The exaggerated increase in the prevalence of obesity in the last 20 years has been favored 
by changes in the environment that determine the increasing energy input and the reduction 
of the physical activity, included individuals without genetic predisposition. 
The environment influence can initiate since gestation. Diverse studies have related obesity 
with prenatal exposure to an excess of caloric intake, diabetes, smoking and the lack of 
breastfeeding (Dabelea, et al., 2000; Power & Jefferis, 2002; Silverman et al., 1998). 
The weight gain is very common in people that quit smoking. This fact has been attributed 
to the suppression of nicotine exposure. The average weight gain is about 4 - 5 Kg in 4 to 6 
months. It has estimated that suppression of smoking increase to 2.4 times the risk of obesity 
in comparison to non smoking people (Flegal, 1995). 
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The increasingly sedentary lifestyle is an important determinant of obesity. Some authors 
suggest that the decrease in energy expenditure may have more impact than the increase in 
the caloric intake (Prentice & Jebb, 1995). A health study reported that watching television 
for 2 hours a day is associated with an increment of about 23 and 14% of obesity and 
diabetes risk respectively (Hu et al., 2003).  The reduction in the number of hours watching 
television has been demonstrated to decrease the appearance of obesity (Robinson, 1999) 
Obesity is more prevalent in adults with physical or sensorial incapacity, or with mental 
diseases (Levine et al., 2000). 
The relationship between environment and physiology is an important factor on the obesity 
epidemic in industrialized countries. It has emerged an abundant availability of food; the 
food intake prevails at the end of day and the physical activity has been reduced. This 
supposed “environment mutation” causes that the susceptible central nervous system (CNS) 
loses its capability to detect the internal and external rhythm. Since CNS employs the 
autonomous nervous system (ANS) to regulate internal rhythm, it has been proposed that 
unbalance and loss of rhythm could be the most important mechanisms in the origin of the 
metabolic syndrome. The metabolic syndrome is a clinic concept that is characterized by the 
association of Diabetes Mellitus, glucose intolerance, hypertension, central obesity, 
dyslipidemia, micro albuminury and atherosclerosis (Kreier et al., 2003). 
Psychosocial factors 
There are descriptions about some psychiatric disorders related to obesity. The “night eating” 
syndrome is defined as the consumption of at least 25% (generally more than 50%) of the 
energy between dinner and the next morning breakfast. It is an eating disorder of the obese 
that is accompanied by sleeping disorders and it has been considered as a component of the 
sleep apnea. It occurs in 10-64% of the obese subjects. Binge eating disorder is a psychiatric 
disease characterized by ingesting large amounts of food in a relatively short time period, with 
the subjective feeling of control loss and without a compensatory behavior. Its prevalence is 7.6 
to 30% in different groups of obese (Stunkard et al., 1996). Progressive hyperphagic obesity 
starts from childhood, and affected individuals which generally exceed 140 Kg of weight at 
age 30 (Bray, 1976). Obesity is more prevalent in subjects of low socioeconomic level, but it has 
not determined the precise reason of this finding.  
Although increasingly new evidence about genetic influence and neuroendocrine unbalance 
of obesity are emerging, is necessary to consider a holistic model in which the biological and 
psychological factors interact in a complex way. Thus we can expect better results in the 
comprehension, prevention and treatment for this important health problem. 
There have been many attempts to find an adequate treatment that contributes to diminish the 
amount of body fat of individuals that for any of the previously mentioned reasons have 
acquired a Body Mass Index (BMI) above to the standard established for health care (Figure 5). 
Due to the multifactorial etiology of this disease, it has been complicated to find a unique or 
standard therapeutic, since each individual has a different development of the disease. 
Looking for options that can contribute to the decrease of the exceeding body fat in the 
population that have obesity, it has been observed that some populations tend to develop in 
a lesser frequency this disease, such is the case of the eastern populations which have an 
obesity incidence about 5% in subjects over 18 (WHO, 2002), compared to the highest 
incidence in countries as USA, where 1 of every 3 habitants are obese. It has been observed 
that the eastern populations have healthier life styles and also a diet where soybeans have 
long been a major component. 
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BODY MASS INDEX (BMI) 
IS ONE OF THE MOST IMPORTANT CRITERIA TO KNOW THE 
NUTRITIONAL STATUS OF ADULTS, CONSIDERING FACTORS 
AS  CURRENT WEIGHT, HEIGHT AND SEX OF THE PERSON 
 
PARAMETERS ARE RANGING FROM  18 TO  24.9 
BMI 
OBESITY:     27 
OVERWEIGHT :  Over 25 and under 27 
Malnutrition :  EQUAL TO OR LESS THAN 18 
http://www.issste.gob.mx/aconseja/índice.html 
Fig. 5. BMI, over 80 developing countries have adopted BMI as part of their national policy 
to improve child health (WHO, 2002). 
3. Soybean 
Chemical composition 
Soy (Glycine max, family Leguminosae, subfamily Papilionoidae) is a species of legume 
native to East Asia. The height of the plant varies from 0.50 m to 1.50 m. It has large trifoliate 
and pubescent leaves and the fruit is a hairy pod that grows in clusters of 3–5, and usually 
contains 2–4 spherycal or elongate seeds (Figure 6). This legume has important feeding 
characteristics. Japan was the first country to consider the nutritional benefits of the 
soybean. The protein concentration of the soybean is the largest of all legumes. The soybean 
contains in sufficient amount the indispensable amino acids to satisfy the healthy adult 
requirements (Ridner, 2006). This legume also has lipids that are rich in poly-unsaturated fat 
acids, standing out for the high content of linoleic acid (51%). Approximately 1.5 to 2.5% of 
the lipids present in the soybean are found as lecithin, this has an emulsifier function. We 
can found also in considerable proportions tocopherols and vitamin E, both of them can act 
as antioxidants (FAO, 1992) 
 
 
Fig. 6. Soybeans. Soy its a legume containing between one and four yellow or black seeds 
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This is the legume with the highest content of galactooligosaccharides, which constitute an 
important prebiotic (Ridner, 2006). The soybean also has significant amounts of minerals 
like: calcium, iron, copper, phosphorus and zinc; however, the availability seems 
diminished by the presence of phytate; this disadvantage decreases with cooking, 
fermentation or germination process (FAO, 1992).  
In addition, soybean contains a series of compounds which are known to have specific 
functions in both the plant and the organisms that consume it; such as the isoflavones 
genistein, daidzein and glycitein (Figure 7), as well as flavonoids, lignin, saponins and 
sterols. Some of them have showed to have antioxidant capacity (Dixon, 2004; Mikstacka et 
al., 2010). 
 
 
Fig. 7. Soy Isoflavones. Isoflavones comprise a class of organic compound, often naturallity 
occurring, related to the isoflavonoids. Many act as phytoestrogens and antioxidants.  
Soybean and obesity 
Metabolic syndrome is a combination of medical disorders that increase the risk for 
cardiovascular disease and Type II diabetes. Obesity may lead to metabolic syndrome 
because it increases the prevalence of visceral obesity, insulin resistance, increased very low-
density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol, decreased high-
density lipoprotein (HDL) cholesterol, elevated triglycerides, hypertension (high blood 
pressure), and fatty liver, which are important factors of metabolic syndrome. 
Visceral obesity, a hallmark for the male obese phenotype, which is characterized by excess 
fat storage around the abdomen, is the prime cause of metabolic abnormalities; therefore, 
men are usually at higher risk of cardiovascular disease than women. Along with the 
realization of many studies it has been observed that animals and humans fed with seeds of 
soybean tend to lose more weight than those who were fed animal protein such as casein 
(Hurley et al., 1998; Iritani et al., 1997). 
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The mechanisms of action by which the soy protein isolates have beneficial effects on 
obesity are not completely clear yet. However, there are many studies confirming that 
different components included in the soybean have specific functions in the human body 
such as the absorption of the lipids, the insulin resistance, fat acid metabolism and other 
hormonal, cellular and molecular changes related with adipose tissue (Wang & González, 
2005). 
Soybean, obesity and Diabetes Mellitus II 
Murine Models 
Some researches performed on animal models have demonstrated that the consumption of 
soy has effects on the diminution of glucose levels and in insulin resistance, and also the 
increase in insulin receptors. Hurley et al. (1998) examined the metabolic effects of different 
types of protein in male Sprague-Dowley rats. Plasma glucose and insulin concentrations, in 
addition to total and metabolizable energy intake and body weight gain, were lower in rats 
fed soy protein isolate- cornstarch diet compared with casein-cornstarch diet. In the study of 
Lavign et al. (2000), it was evaluated the effect of feeding different types of proteins (cod, 
soy and casein) in Wistar rats finding that cod and soy protein improved fasting glucose 
tolerance and peripheral insulin sensitivity when compared with casein. 
Subsequently, based on these findings, further studies were done in animal models with 
specific features of obesity and various chronic degenerative diseases. 
Iritani et al. (1997) investigated the effects of different dietary fatty acids and proteins on 
glucose tolerance and insulin receptor gene expression, in Wistar fatty rats (genetically 
obese, noninsulin-dependent diabetes mellitus). After three weeks, dietary soybean protein 
could help to reduce the insulin resistance, but only when a diet low in polyunsaturated 
fatty acids was consumed. In addition, dietary soybean protein stimulated insulin receptor 
gene expression in comparison with casein. 
Another possible mechanism of action of soy protein is by stimulation of adiponectin, a 
cytokine produced by fat cells that has an important role in regulating differentiation and 
secretory function of adypocytes by increasing insulin sensitivity (Anderson et al, 2004). 
High blood levels of this hormone reduce obesity (Arita et al, 1999; Weyer et al,. 2001). There 
is a report indicating that the consumption of soy isolate reduces the adiponectin 
concentration in Wistar rats genetically engineered to develop obesity (Dietze et al., 2005). 
In another study it was compared the effects with an energy-restricted diet, low fat intake 
(5%) and high protein content (35%) from soy and casein in male genetically obese yellow 
KK mice. The plasma total cholesterol and glucose levels as well as the body fat and body 
weight were lower in mice fed soy protein isolate (SPI) compared to group fed whey protein 
isolate (Aoyama et al., 2000). 
Nagasawa et al. (2002) studied the effects of energy-restricted diet containing soy protein 
isolate (SPI) on body composition, blood glucose, lipid and adiponectin levels and the 
expression of genes involved in the metabolism of glucose and fatty acid in male obese mice 
KK-A. Body weight and brown adipose and mesenteric tissues were lower in animals fed 
SPI compared with animals fed casein diet. There no was significant difference in gene 
expression between both diets. It was concluded that SPI diminishes body fat quantity and 
glucose levels more efficiently than hypocaloric diets based in casein in obese mice. 
The content of isoflavones of the soy protein is important to the antiobesity effect, because 
has been shown to decrease fat accumulation in animal models of obesity (Manzoni et al., 
2005; Banz et al., 2004).  
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Human research 
Positive results obtained with murine models supported researches to evaluate the effect of 
SPI diets in human subjets. 
Mikkelsen et al. (2000) compared the effect of feeding low-fat diets containing pork, soy 
protein or carbohydrates in 12 young people with overweight and grade II obesity and a 
body mass index (BMI) between 26 and 32. Energy expenditure was measured in a 
respiratory chamber and was significantly higher (by >3%) in subjects consuming protein-
rich diets. This indicates that protein has a thermogenic and satiety effect greater than 
carbohydrates, a fact that may be relevant in the prevention and treatment of obesity. 
Allison et al. (2003) evaluated the efficiency and the safety of a low-calorie diet based on soy 
in the treatment of obesity in obese individuals. Soy diet induced a higher weight loss than 
animal protein diet. Anderson et al. (2004) demonstrated, in human studies, that SPI 
consumption had an effect on reduction of appetite compared to egg protein. 
In another study (Deibert et al, 2004) it was compared diets from two different lifestyles 
(balanced nutrient reduction diet, and soy protein substitution diet with and without 
physical activity program). It was shown that a high-soy-protein low-fat diet induced a 
higher weight loss through fat but not muscle mass in overweight and obese people. 
Soybean, obesity and cardiovascular diseases 
Murine models 
There are in vivo evidences showing that soy protein influences the lipogenesis on the liver. 
It was demonstrated that triglycerides (TGC) in the blood and especially in the liver were 
decreased by the consumption of a diet with a protein input based on soybean. These effects 
were associated with the activity reduction of lipogenic enzymes, particularly 
dehydrogenase 6-phosphate, malic enzyme, synthetase fatty acid, as well as acetyl CoA 
carboxylase (ACC) meaning that soy protein decreases the liver TGC inhibiting the 
synthesis in the same  (Xiao et al., 2006) 
Recently in a study with obese Zucker rats that were fed isoflavones-rich SPI, it was showed 
a decrease on fatty liver and reduced alanine and aspartate transaminases levels in plasma. 
These effects were accompanied by an increase in mitochondrial and peroxisomal ǃ-
oxidation activity and acetyl CoA carboxilase activity, among others. The ACC is the rate 
limiting enzyme in catalyzing the carboxylation of acetyl CoA to form malonyl CoA  and is 
the main enzyme in the biosynthesis of long chain fatty acids. Aoki et al.  (2006) reported 
that SPI feeding decreased the hepatic contents of ACC alpha mRNA mainly by regulating 
PI promoter in rats. 
In addition, it was shown that soy protein decreased levels of TGC in rat liver also reducing 
the adipose tissue weight. These changes were associated with increased gene expression of 
skeletal muscle enzymes which produce the fatty acid oxidation, including carnintin 
palmitoyl-transferase (CTP1), ǃ-hydroxyacyl-CoA dehydrogenase (HAD), acyl CoA-oxidase 
and the medium-chain acyl CoA-dehydrogenase activities. 
 It has been reported that soybean saponins can also reduce serum cholesterol (Oakenful et 
al, 1984), but their role in lipid metabolism is not completely clear. A study on hamsters 
reported that a diet containing soy saponins without isoflavones induced a reduction in 
cholesterol and TGC levels as well as in total cholesterol/HDL ratio. The phospholipids may 
have an antilipidemic effect, since they reduced the hepatic synthesis of fatty acids along 
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with the malic enzyme, glucose-6-phosphate dehydrogenase and pyruvate kinase activities 
in a study in rats (Rouyer et al, 1999). 
Human studies  
The consumption of soy protein in a group of patients with hyperlipoproteinemia, reduced 
the low density lipoproteins (LDL) cholesterol and TGC levels by 16.4% and 15.9%, 
respectively, in blood and liver, besides to reduce intestinal absorption of endogenous and 
exogenous cholesterol (Wright & Salter, 1998). Soy protein has also been shown to directly 
affect LDL hepatic metabolism and the activity of LDL receptors. Lovati et al. (1987) found 
that SPI diet dramatically affected the degradation of LDL by mononuclear cells. 
In another research in humans, it was found that soybean can reduce the insulin/glucagon 
ratio which increases its antihypercholesterolemic effect (Gudbrandsen et al., 2006; Hubbard 
et al., 1989). In a similar work it was evaluated the effect of a hypocaloric diet containing 
casein or soy protein in a long and short term assays. The measured parameters were body 
weight reduction in subjects with 50% over ideal weight and lipoproteins levels. All 
participants lost weight (in a similar way in both diets), but the high density lipoproteins 
(HDL) level was lower in individuals consuming casein. Authors concluded that soy protein 
could have a greater benefit than casein in patients who need hypocaloric diet for long 
periods (Bosello et al., 1998).  
In a twelve-week trial with obese subjects, it was compared the soy protein effects against 
milk protein in hypocaloric diets of 1200 kcal/day. People who consumed soy lost more 
weight than those who consumed milk (9% vs 7.9%) but the difference was not statistically 
significant. However, the reduction of LDL cholesterol and TGC levels were significant 
(Anderson et al., 2005). 
Soy and its relation with PPAR and SREBP-1 
The type of foods that are ingested has effect in the phenotype of an individual by 
modulating transcription factors that modifies the expression of genes and determines 
individual characteristics. 
The transcriptional control of these genes is mediated by a family of transcription factors 
designated as sterol regulatory element binding proteins (SREBPs) (Torres, 2006). The 
isoflavones acts through multiple mechanisms that include inhibition of cholesterol 
synthesis and esterification of fat (Orgaard & Jensen, 2008). Isoflavones regulate the activity 
or the expression of SREBP-1. In addition, SREBP-1 regulates the expression of stearoyl–CoA 
desaturase 1 (SCD-1), D5 desaturase and D6 desaturase involved in fatty acid desaturation 
to form monounsaturated and polyunsaturated fatty acids. The balance between saturated, 
monounsaturated and polyunsaturated fatty acids is essential for the formation of 
triglycerides and phospholipids in the liver. Hepatic SCD-1 activity determines the 
metabolic fate of endogenous lipids, driving newly synthesized fatty acids preferentially to 
triglyceride esterification and very LDL (VLDL) assembly and secretion rather than 
mitochondrial influx and C-H oxidation (Torres, 2006). Soy protein causes an increase in bile 
acid secretion and inhibits intestinal cholesterol absorption.  
The mechanisms by which soy protein prevents triglyceride accumulation are by reducing 
hepatic fatty acid and triglyceride biosyntheses and by increasing fatty acid oxidation 
through the activation of the transcription factor peroxisome proliferator-activated receptor 
ǂ (PPARǂ). PPARǂ is a ligand-dependent transcription factor of the nuclear receptor 
superfamily. A soy protein diet up-regulates PPARǂ gene expression (Tovar, 1998). PPARǄ 
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is highly expressed in adipose tissue and is involved in critical physiological functions such 
as adipogenesis and glucose and cholesterol metabolism. This transcription factor induces a 
preadipocyte differentiation program leading to mature functional adipocytes. PPARǄ 
stimulates fatty acid uptake and triglyceride esterification in a concerted action with SREBP-
1 that regulates lipogenesis to fill the lipid droplet. The differentiation of adipose tissue 
protect to other organs of fat accumulation called lipotoxicity. Many studies have 
demonstrated that the soy protein associated isoflavone genistein is able to activate PPARǄ, 
resulting in an up-regulation of adipogenesis and probably fatty acid uptake from plasma 
(Mezei, 2003).  
Another molecule related in the energy homeostasis is AMP-activated protein kinase 
(AMPK). AMPK induces a cascade of events within cells in response to the ever changing 
energy charge of the cell. The role of AMPK in regulating cellular energy charge places this 
enzyme at a central control point in maintaining energy homeostasis. In a recent research 
the consumption or administration of soy peptides increased AMPK level, and promoted 
the fat mass loss (Jang, 2008).   
Soybean germination, obesity and cardiovascular diseases 
Germination of soybean and changes in chemical composition and aminoacid profile 
Germination is a simple, low-cost process that produces a natural product, eliminates or 
inactivates certain antinutritional factors, and increases the digestibility of proteins and 
starches in legumes. Germination process has been developed to overcome the disadvantage 
of soybean seeds used in food products. Germination causes changes in secondary 
metabolite distribution, mobilizes the reserve proteins stored in the cotyledon protein 
bodies, changes amino acids composition (Davila et al., 2003) and produces intermediate 
molecular weight peptides (Mora-Escobedo et al., 2009). Germination could improve the 
nutritional and nutraceutical properties of legumes by modifying metabolites content and 
generating peptides and amino acids with possible biological activity. Paucar-Menacho et 
al., (2009) found that germination of soybean for 42 h at 25 °C resulted in an increase of 
61.7% of lunasin, decrease of 58.7% in lectin and 70.0% in lipoxygenase activity. Optimal 
increases in the concentrations of isoflavone aglycones were observed in combination of 63 h 
of germination and 30°C. A significant increase of 32.2% in the concentration of soy 
saponins was observed in combination of 42 h of germination at 25 °C.  
Our group conducted an investigation in which soybean seeds (BM2 donated by the 
Forestry Research Institute of Agricultural and Livestock, INIFAP, México) were 
germinated according Mora-Escobedo et al. (2009). The germinated seeds were harvested 
at different times (0, 48, and 72 h), lyophilized and ground. In order to evaluate the effect 
of germination on the main nutrients provided by the soybeans, were characterized the 
flours obtained at different times of germination. Table 1 shows the results. The protein 
content of the soybean was of  34.85 ± 0.65 to 35.63 ±0.87, with no significant difference 
(p> 0.05) between different times of germination. In germinated flour was an increase in 
the lipid content of 11.14% (p ≤0.05) for 48 h and 16.18% (p <0.05) for 72 h compared to 
ungerminated flour. The increase in lipid content observed in this study probably was 
due to the decrease of other seed components, as some carbohydrates. Paredes-López and 
Mora-Escobedo (1989) reported a decrease in starch content of 25% in germinated 
amaranth flour by 72 h. 
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Soybean flour Carbohydrates Protein Fat Ashes 
Ungerminated 37.52 34.85 ± 0.65 22.43  ± 1.04 5.20 ± 0.03 
48h of germination 34.66 35.63 ± 0.87 24.93 ± 0.8* 4.78 ± 0.02 
72h of germination 33.62 35.18 ± 0.64 26.06 ± 0.8* 5.14 ± 0.10 
*p<0.05 regarding non-germinated flour 
Table 1. Composition of soybean flour with different times of germination (g/100 g meal 
dry basis)  
Amino acid content of germinated soybean proteins  
The method proposed by Rickert et al., (2004) was used with slight modifications in order to 
obtain soybean proteins. The protein yield was 59.7%. The total protein content and amino 
acid analysis of germinated soy proteins are shown in Table 2. The protein content in the 
sample obtained at 72 h of germination decreased. The amino acid composition was altered 
significantly compared to the different times of germination. Analyzing the essential amino 
acids, it was observed in the isolate of soy germinated for 48 h, a significant increase (p 
≤0.05), between 10 and 21% for phenylalanine, leucine, threonine, and isoleucine. These 
results were consistent with those reported by Dasinova (1994), who observed an increase of 
5 to 23% in soybean, lentils, barley and wheat sprouts, for the essential amino acids leucine, 
phenylalanine and tryptophan. By extending the germination time to 72 h, this group of 
amino acids showed a more significant increase of 16 to 25%. Valine was the amino acid 
with the greatest increase and it was seen in the germination of 48 h (54.06% at p ≤0.05).  
Lysine is an amino acid important for human consumption, since it intervenes in the 
metabolism of carbohydrates and fats and is needed for protein synthesis. It is the main 
limiting amino acid in cereals, especially wheat. The isolate obtained from soybean 
germinated for 72 h, was able to increase the contribution of lysine by 26% (p ≤0.05). 
Contrary to expectations, the methionine content increased with germination time up to 
23.98% at 72 h (p ≤0.05). This is the limiting amino acid in soy and the germination was able 
to increase their concentration; a significant event when viewed from the nutritional point of 
view. However, methionine is the precursor of homocysteine, a compound that at high 
levels in the blood can be an independent risk factor for cardiovascular disease (Steed & 
Tyagi, 2010).  
The amino acid of interest for this study was arginine. This amino acid was link with the 
decrease in the progression of atherosclerotic plaque and protection against damage 
produced by ischemia-reperfusion (Piñeiro et. al., 2010). In this research after germination 
for 72 h, there was an increase of 8.5% (p ≤0.05). Considering these results it was decided to 
continue the study using the isolated protein obtained from soybeans germinated for 72 h, 
free of isoflavones, because the objective was to study only the effect of proteins, since 
Orgaard and Jensen (2008) studied the effect of soy isoflavones on obesity in humans and 
they found that this effect may depend on whether the isoflavones are consumed in 
combination with soy protein. 
Germination induced degradation of the α and α´ fractions of β-conglycinin, after third day 
of germination generating low molecular weight peptides (Figure 7). At least six 
polypeptides, ranging from 25 to 37 kDa molecular weight, appeared as apparent 
degradation products of ǃ-conglycinin (Mora-Escobedo et al. 2009). Analyzing the 
electrophoretic profile, it is demonstrated that there was a turnover of proteins and 
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 Ungerminated 
48 h of 
germination 
72 h of 
germination 
Proteins 84.6% 81.39% 76.90% 
Essential amino acids 
(g/100 g of protein) 
   
Valine 3.64 5.60* 4.12 
Isoleucine 3.33 4.05* 4.17* 
Treonine 3.48 4.09* 4.07* 
Fenilalanine 4.96 5.48* 5.83* 
Leucine 7.46 8.42* 8.67* 
Lisina 5.61 5.91 7.06* 
Metionine 0.98 1.19* 1.22* 
Cisteíne 1.37 1.64* 1.68* 
Non essential amino 
acids (g/100 g of protein) 
   
Histidine 2.43 2.69 2.69 
Aspartic Acid 11.47 11.95* 12.29* 
Serine 7.69 8.3* 8.32* 
Glutamic Acid 18.58 18.36 17.93* 
Proline 5.18 5.32 5.28 
Glicine 4.32 4.76* 5.67* 
Alanine 4.27 5.07* 5.12* 
Tirosine 3.68 4.41* 4.51* 
Arginine 4.90 5.07 5.31* 
*p<0.05 regarding non-germinated flour 
Table 2. Protein and aminoacid content of soybean proteins obtained at different times of 
germination of BM2 variety. 
 
 
Fig. 7. Electrophoretic profile of the soy protein isolates germinated at different times 
(0-6 days) (Mora-Escobedo, 2009). 
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nonprotein nitrogen; equilibrium resulting of the degradation and synthesis processes 
during germination.  
Biological experiments 
Rat experimental design: 27 female rats were randomly distributed in 3 groups with 9 rats 
each. Group 1 (control): hypercholesterolemic diet (HCD); Group 2 (soybean): 0.43 g of 
germinated soybean protein/Kg of weight and Group 3 (blank): milled Rodent chow 5008. 
The weight of the rats was registered in order to adjusting the doses. HDC was: Cholesterol 
1% (C8503, Sigma), Sodium Cholate 0.5% (C1254, Sigma), butter without salt 5%, glass sugar 
30%, casein 10% (Teckland, MA) and Rodent food 5008 53.5% (Matsuda, 1986). The soybean 
protein/ treatment were administered orally for a period of 40 days. On day 40, myocardial 
infarction was provoked in all animals, following the procedure reported by Piñeiro et al., 
2010.  
Table 3 shows weight increase of different groups at the end of the treatment. Analyzing 
body weight in all groups it was observed a significant decrease in Group 2 (p ≤ 0.05). It was 
an important finding since it indicates that consumption of soy protein may help control 
weight. Bau et al., (2000) found that a diet rich in germinated soybean seeds may possibly 
have beneficial effects in preventing obesity (Bau et al., 2000). On the other hand the results 
found in this work showed protein soy tendency to diminish the problems generated by 
ischemic reperfusion and then it is possible to say that the changes in aminoacid profile 
could be responsible for the protector effect. 
 
 
Group 1 
(Control) 
Group 2 
(Soybean) 
Group 3 
(Blank) 
Weight increase (%) 41.5 ± 6.24 37.67 ± 5.03* 34.5 ±4.45* 
Heart (relative 
weight) 
0.47 ± 0.05 0.43 ± 0.03 0.44 ± 0.07 
HAA/TA 0.75 0.59 0.58 
*Significant difference (p<0.05) respecting to control. Relative weight: heart weight/100 g of rat weight. 
HAA/TA=Heart attack area/Total area.  
Table 3. Weight increase; heart relative weight and damaged area in dyslipidemic rats 
Studies in vitro and in vivo suggest that consumption of soy protein have favorable effects on 
obesity and lipid metabolism. Cell culture has been used as a model for the study of obesity, 
supporting the study of phenomena such as disorders in the metabolism of carbohydrates 
and lipids. It is useful to elucidate the possible mechanisms by which soy protein has 
beneficial effects on diabetes, cardiovascular disease and obesity (Jang et al, 2009; Gonzalez, 
et al. 2009; Tsou, et al. 2010).  
Taking into account the results obtained with studying the germinated soy protein it was 
realized an in vitro study of antiobesity effect of germinated soy proteins using 3T3-L1 
adiposities. This research was done to determine if germination improves the antiobesity 
properties of soybean protein through generation of amino acids or bioactive peptides. 
Soybean was germinated during 1 to 6 days and proteins were isolated from germinated 
samples. The protein isolates were hydrolizated by sequential in vitro digestion using pepsin 
and pancreatin, the protein profile was observed by SDS-PAGE.  
These hydrolysates were tested in 3T3-L1 cells (mice fibroblast) differentiated into 
adiposities. The amount of accumulated lipid was measured by red oil technique. Degrees 
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of hydrolysis ranged from 60-63%. The 2 days germinated soy protein hydrolysate with 
isoflavones had the best effect antiadipogenic. These results indicate that the consumption 
of germinated soybean could have an impact on reducing body fat and thereby mitigate the 
effect of obesity, promoting the use of germinated soybean for the elaboration of functional 
foods. The development of products from germinated soybean could further increase the 
versatility and utilization of soybean.  
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